Display options
Share it on

Indian J Nucl Med. 2015 Jan-Mar;30(1):75-7. doi: 10.4103/0972-3919.147553.

Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in evaluation of residual intramuscular myxoma.

Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Anand Zade, Archana Ahire, Shishir Shetty, Sujith Rai, Rajashekharrao Bokka, Arokiaswamy Velumani, Rasika Kabnurkar

Affiliations

  1. Department of Molecular Imaging, Nueclear Healthcare Ltd., Kopar Khairane, Navi Mumbai, India.
  2. Department of Radiology, Jupiter Hospital, Thane, India.
  3. Department of Oncology, Fortis Hiranandani Hospital, Vashi, Navi Mumbai, India.
  4. Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India.

PMID: 25589814 PMCID: PMC4290074 DOI: 10.4103/0972-3919.147553

Abstract

Intramuscular myxoma (IM) is a rare benign neoplasm. In a patient diagnosed with IM of left thigh, we report the utility of a postoperative fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography scan in assessing the efficacy of surgical excision.

Keywords: Fluorine-18 fluorodeoxyglucose; intramuscular myxoma; positron emission tomography-computed tomography scan

References

  1. Skeletal Radiol. 2003 Apr;32(4):201-8 - PubMed
  2. Histopathology. 1999 Oct;35(4):291-312 - PubMed
  3. World J Surg Oncol. 2012 Jun 30;10:132 - PubMed
  4. Clin Nucl Med. 2009 Apr;34(4):224-5 - PubMed
  5. Skeletal Radiol. 2007 Nov;36(11):1085-9 - PubMed
  6. Radiology. 2002 Oct;225(1):215-24 - PubMed
  7. Skeletal Radiol. 2003 Mar;32(3):133-8 - PubMed
  8. Clin Nucl Med. 2006 Oct;31(10 ):627-9 - PubMed
  9. Int Orthop. 2009 Jun;33(3):605-10 - PubMed

Publication Types